Stock Report

All about this stock under one free report Last Updated: 10-May-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Hi-Tech Drugs Ltd.

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 524424

₹ --

₹ -- (--%)

As on --

Market cap

info icon

--

Revenue (TTM)

info icon

--

P/E Ratio

info icon

--

P/B Ratio

info icon

--

Div. Yield

info icon

--

Hi-Tech Drugs Share Price

Compare

Max:loading Min:loading

Max:loading Min:loading

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: High:

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    --

  • ROEROE information

    --

  • ROCEROCE information

    --

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    --

  • Debt to EquityDebt to Equity information

    --

  • Book ValueBook Value information

    --

  • EPSEPS information

    --

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    --

Years Aggregate

CFO

--

EBITDA

--

Net Profit

--

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
BSE Sensex
-8.7 3.6 -7.5 -4.2 8.2 9.5 11.9
BSE Healthcare
7.1 11.7 10.9 10.9 26.2 14.1 11.7
As on 08-May-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in ( Cr)

Annual

*All values are in ( Cr)

Annual

*All values are in ( Cr)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Hi-Tech Drugs

Manufacture of allopathic pharmaceutical preparations

  • Incorporated

    1988

  • Chairman

    --

  • Managing Director

    --

  • Headquarters

    Ratlam, Madhya Pradesh

  • Website

    NA

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

Announcements

View Announcements

No News & Announcements are available.

FAQs for Hi-Tech Drugs



The 52-week high and low of Hi-Tech Drugs Ltd are Rs -- and Rs -- as of 10-May-2026.

Hi-Tech Drugs Ltd has a market capitalisation of -- as on . As per SEBI classification, it is a company.

Before investing in Hi-Tech Drugs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.